Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 7/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28359369 | 0.82 | ADRA2A (0.35) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL17076294 | 0.79 | TSHR (0.33) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL572696 | 0.79 | CHRM1 (0.37) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL22092461 | 0.77 | TSHR (0.38) | ADRA2AADRA1ATSHRACHESMN1; SMN2 | |
| SCHEMBL28453108 | 0.77 | ADRA2A (0.35) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL28765598 | 0.75 | TSHR (0.41) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL17076331 | 0.74 | HPGD (0.31) | ADRA2AADRA1ATSHRCHRM5CHRM1 | |
| SCHEMBL29080623 | 0.74 | CHRM5 (0.37) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL28425876 | 0.72 | TSHR (0.37) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL21522644 | 0.71 | CHRM5 (0.38) | ADRA2AADRA1AMAPTBLMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3132810-B1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS-LINKED POLYPHOSPHORYLCHOLINE | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2025-10-29 | — | — | EP | claimed |
| US-20250197922-A1 | NUCLEIC ACID AMPLIFICATION PROMOTER AND TEST METHOD USING SAME | NOF CORPORATION (JP) | 2025-06-19 | — | — | US | claimed |
| EP-4410994-A1 | NUCLEIC ACID AMPLIFICATION PROMOTER AND TEST METHOD USING SAME | NOF Corporation (JP) | 2024-08-07 | — | — | EP | claimed |
| US-20240110235-A1 | REACTION COMPOSITION FOR NUCLEIC ACID AMPLIFICATION AND NUCLEIC ACID AMPLIFICATION METHOD USING SAME | NOF CORPORATION (JP) | 2024-04-04 | — | — | US | claimed |
| US-11925547-B2 | Prosthesis for in vivo insertion, coated with cross-linked polyphosphorylcholine | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-03-12 | — | — | US | claimed |
| WO-2023234365-A1 | SOFT CONTACT LENS HAVING COATING LAYER | 日油株式会社 | 2023-12-07 | — | — | WO | claimed |
| WO-2023120447-A1 | STERILIZATION COMPOSITION AND STERILIZATION METHOD | 日油株式会社 | 2023-06-29 | — | — | WO | claimed |
| CN-116265033-A | Long-acting anticoagulation coating and plasma preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2023-06-20 | — | — | CN | claimed |
| US-20230124809-A1 | COMPOSITION FOR ORAL CAVITY | NOF CORPORATION (JP) | 2023-04-20 | — | — | US | claimed |
| WO-2023054340-A1 | NUCLEIC ACID AMPLIFICATION PROMOTER AND TEST METHOD USING SAME | 日油株式会社 | 2023-04-06 | — | — | WO | claimed |
| CN-114502362-A | Contact lenses with surfaces of varying softness | 爱尔康公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114080226-A | Ophthalmic composition | 爱尔康公司 | 2022-02-22 | — | — | CN | claimed |
| CN-110831990-B | Poly (meth) acrylamide-based copolymers with carboxyl-terminated side chains | 爱尔康公司 | 2022-02-01 | — | — | CN | claimed |
| US-20210378814-A1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS-LINKED POLYPHOSPHORYLCHOLINE | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2021-12-09 | — | — | US | claimed |
| CN-109689798-B | Method for producing water-soluble thermally crosslinkable polymer materials | 爱尔康公司 | 2021-10-15 | — | — | CN | claimed |
| US-11129706-B2 | Prosthesis for in vivo insertion, coated with cross-linked polyphosphorylcholine | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2021-09-28 | — | — | US | claimed |
| CN-111919141-A | Silicone hydrogel contact lenses | 爱尔康公司 | 2020-11-10 | — | — | CN | claimed |
| CN-111566517-A | Contact lenses having lubricious coating thereon | 爱尔康公司 | 2020-08-21 | — | — | CN | claimed |
| EP-3132810-A1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS-LINKED POLYPHOSPHORYLCHOLINE | Seoul National University R&DB Foundation (KR) | 2017-02-22 | — | — | EP | claimed |
| US-20170035555-A1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS- LINKED POLYPHOSPHORYLCHOLINE | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2017-02-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230124809-A1 | COMPOSITION FOR ORAL CAVITY | TAS2R10, TAS2R40, TAS2R20 | ADRA2A 4212/4885ADRA1A 4474/4885MAPT 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.